This multicenter, randomized, double blind clinical trial was conducted in the Internal Medicine and Therapeutics Department at the University of Pavia and in the G Descovich Atherosclerosis Study ...

Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the renin–angiotensin system slows the progression of renal disease in patients with type 1 diabetes, but similar ...

This study demonstrates that candesartan had greater efficacy in lowering arterial pressure when compared to losartan. Moreover, the duration of effect and response/control rates were significantly ...